Literature DB >> 541409

Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection.

G Alfredsson, G Sedvall, F A Wiesel.   

Abstract

A high-performance liquid chromatographic method for the analysis of sulpiride, N-ethyl-2-(2-methoxy-5-sulphonamido-benzamido-methyl)-pyrrolidine, in body fluids is described. A structurally related compound, N-ethyl-2-(2,4-dimethoxy-benzamido-methyl)-pyrrolidine, was used as internal standard. A fluorescence detector with excitation maximum at 299 nm and emission maximum at 342 nm was used for the quantitation. The detection limit was about 10 ng/ml in serum and cerebrospinal fluid and about 200 ng/ml in urine. The experimental error was 5--10% in the concentration range 25--100 ng/ml. Some preliminary data from a pharmacokinetic study in healthy volunteers are presented. The half-life for sulpiride in serum was about 8 h. Sulpiride was also measured in cerebrospinal fluid from five drug-treated psychotic patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 541409     DOI: 10.1016/s0378-4347(00)81187-1

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

Review 1.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

2.  Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.

Authors:  G Alfredsson; C Härnryd; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.

Authors:  G Alfredsson; C Härnryd; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.

Authors:  G Wik; F A Wiesel; I Sjögren; G Blomqvist; T Greitz; S Stone-Elander
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.

Authors:  F A Wiesel; G Alfredsson; M Ehrnebo; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.

Authors:  F A Wiesel; G Alfredsson; M Ehrnebo; G Sedvall
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

7.  Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.